Lumentum's 1,500% AI Rally Clashes with DeepValue's Strong Sell on Overvaluation and Cyclical Risks

What happened

Lumentum's stock has surged over 1,500% in the past year, driven by hype around its AI optical components and catalysts like Nvidia deals, as highlighted in recent news. However, DeepValue's master report reveals that at ~$435, the stock trades at extreme valuations—P/E of 122x and EV/EBITDA of 314x—with no margin of safety, pricing in perfect AI demand sustainability. The company faces significant headwinds including ongoing commoditization, intense competition from peers like Coherent, and unresolved export-control investigations that could disrupt access to key Asian customers. Management's own filings warn of ASP erosion, high customer concentration without long-term commitments, and margin gains partly reliant on non-recurring charges rather than structural pricing power. Thus, the market's euphoria appears to overlook these fragile fundamentals, setting the stage for potential sharp corrections if AI capex slows or risks materialize.

Implication

The stock's current price implies unsustainable AI capex growth, ignoring normalizing pricing in optical components that could compress margins and trigger multiple derating. High leverage with net debt to EBITDA near 20x and covenant risks amplify vulnerability during any demand downturn, potentially forcing unfavorable refinancing or dilution. Any slowdown in hyperscaler spending or faster-than-expected competition from rivals like Coherent could lead to significant downside, with DeepValue's bear case implying ~30% drop to $300. Key monitoring points include Q3 FY26 results versus $805M revenue guidance, updates on BIS/DOJ export-control inquiries, and trends in excess inventory charges. Prudent investors should lock in gains or wait for a more attractive entry below $260, where some margin of safety might emerge per DeepValue's assessment.

Thesis delta

The news article confirms Lumentum's AI-driven rally but does not alter DeepValue's Strong Sell thesis; instead, the extreme price surge reinforces overvaluation concerns as the stock now trades above even the base case scenario value of $430. The core risks—cycle dependence, commoditization, competition, and regulatory exposure—remain unaddressed and are heightened by the elevated price, making the bearish view more urgent rather than shifting.